Abstract
The purpose of this paper is to report on the construction of the HIV Medication Self-Reported Nonadherence Reasons (SNAR) index and its psychological correlates. Data were derived from a sample of 193 Swedish HIV-seropositive women and men receiving antiretroviral medications. Participants who reported dosing and/or scheduling and/or dietary instructions nonadherence in the past 7 days were presented with a modified AACTG list of 18 reasons for nonadherence. From these data, two conceptually and statistically independent factors were obtained, which accounted for 39% of the variance in the data. These factors were used as the basis for constructing two composite measures composing the SNAR index: the Medication concerns scale and the Routine disruption scale. The Medication concerns scale correlated significantly to suboptimal dose and scheduling adherence and Routine disruption scale with poorer dietary instructions adherence. Psychological distress was the best predictor of the SNAR index. The SNAR index has a clearly interpretable factor structure that allows the derived scales to be useful as multi-item measures of self-reported reasons for nonadherence to HIV antiretroviral medications. The psychological factors found to be associated with the index may imply a number of mental-health-related interventions to improve adherence, which deserve further exploration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., Vecchiet, J., D'Arminio Monforte, A., Wu, A. W., and Antinori, A., for the AdlCoNA Study Group. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Jour nal of Acquired Immune Deficiency Syndrome, 31(Suppl. 3), S123-S127.
Bangsberg, D. R., Bronstone, A., and Hofman, R. (2002). A computer/ based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy. AIDS Care, 1, 3–15.
Beck, A., Weissman, A., Lester, D., and Trezler, L. (1974). The measurement of pessimism: The Hopelessness scale. Journal of Consulting and Clinical Psychology, 42, 861–865.
Cederfjäll, C. (2002). Aspects of care among HIV-infected patients. Needs, adherence to treatment and health related quality of life. PhD Dissertation, Karolinska Institute.
Chesney, M. A., Ickovics, J. R., Chambers. D. B., Gifford, A. L., Neidig, J., Zwickl, B., and Wu, A. W., Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12, 255–266.
Derogatis, I., and Melisatanos, N. (1983). The Brief Symptom Inventory: An introductory report. Psychological Medicine, 13, 595–605.
Gordillo, V., Del Arno, J., Soriano, V., and Gonzalez-Laboz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763–1769.
Horowitz, M. J. (1979). Psychological response to serious life events. In V. Hamilton and D. M. Warburton (Eds.), Human stress and cognition (pp. 235–253). Chicester: John Wiley & Sons.
Ickovics, J. R., and Meade, C. S. (2002). Adherence to antiretroviral therapy among patients with HIV: A critical link between behavioural and biomedical sciences. Journal of Acquired Immune Deficiency Syndrome, 31(Suppl. 3), S98-S102.
Jensen-Fangel, S., Pedersen, L., Pedersen, C., Scade Larsen, C., Tauris, P., Moller, A., Toft Sorensen, H., and Obel, N. (2002). The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1–infected patients. Clinical Infectious Diseases, 35, 1541–1548.
Kleeberger, C. A., Phair, J. P., Strathdee, S. A., Detels, R., Kingsley, L., and Jacobson, L. P. (2001). Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS cohort study. Journal of Acquired Immune Deficiency Syndrome, 26, 82–92.
Molassiotis, A., Nahas-Lopez, V., Chung, W. Y. R., Lam, S. W. C., Li, C. K. P., and Lau, J. (2002). Factors associated with adherence to antiretroviral medication in HIV-infected patients. International Journal of STD and AIDS, 13, 301–310.
Rabkin, J. G., and Chesney, M. (1999). Treatment adherence to HIV medications. The Achilles heel of new therapeutics. In D. G. Ostrow and S. C. Kalichman (Eds.), Psychosocial and public health impacts of new HIV therapies (pp. 61–82). New York: Kluwer Academic/Plenum Publishers.
Ross, M. W., Hunter, C., and Condon, J. (1994). The mental adjustment HIV scale measurement and dimensions of response to AIDS/HIV disease. AIDS Care, 6, 407–411.
Singh, N., Berman, S. M., Swindells, S., Justis, J. C., Mohr, J. A., Squier, C., and Wagener, M. M. (1999). Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clinical Infectious Diseases, 29, 824–830.
Walkey, F. H., and McCormick, I. A., (1985). Multiple replication of factor structure: a logical solution for a number of factor problems. Multivariate Behaviour Research, 20, 57–67.
Walsh, J. C., Horne, R., Dalton, M., Burgess, A. P., and Gazzard, B. G. (2001). Reasons for non-adherence to antiretroviral therapy: Patients' perspectives provide evidence of multiple causes. AIDS Care, 13, 709–720.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schönnesson, L.N., Ross, M.W. & Williams, M. The HIV Medication Self-Reported Nonadherence Reasons (SNAR) Index and Its Underlying Psychological Dimensions. AIDS Behav 8, 293–301 (2004). https://doi.org/10.1023/B:AIBE.0000044076.98833.64
Issue Date:
DOI: https://doi.org/10.1023/B:AIBE.0000044076.98833.64